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Type 1 diabetes islet cell autoantigen 512 (ICA512/IA-2) is a
tyrosine phosphatase–like intrinsic membrane protein involved
in the biogenesis and turnover of insulin secretory granules
(SGs) in pancreatic islet b-cells. Whereas its membrane-proxi-
mal and cytoplasmic domains have been functionally and
structurally characterized, the role of the ICA512 N-terminal
segment named “regulated endocrine-specific protein 18
homology domain” (RESP18HD), which encompasses residues
35–131, remains largely unknown. Here, we show that ICA512
RESP18HD residues 91–131 encode for an intrinsically disor-
dered region (IDR), which in vitro acts as a condensing factor for
the reversible aggregation of insulin and other b-cell proteins in
a pH and Zn21-regulated fashion. At variance with what has
been shown for other granule cargoes with aggregating proper-
ties, the condensing activity of ICA512 RESP18HD is displayed
at a pH close to neutral, i.e. in the pH range found in the early
secretory pathway, whereas it is resolved at acidic pH and Zn21
concentrations resembling those present in mature SGs. More-
over, we show that ICA512 RESP18HD residues 35–90, preced-
ing the IDR, inhibit insulin fibrillation in vitro. Finally, we found
that glucose-stimulated secretion of RESP18HD upon exocyto-
sis of SGs from insulinoma INS-1 cells is associated with cleav-
age of its IDR, conceivably to prevent its aggregation upon expo-
sure to neutral pH in the extracellular milieu. Taken together,
these findings point to ICA512 RESP18HD being a condensing
factor for protein sorting and granulogenesis early in the secre-
tory pathway and for prevention of amyloidogenesis.
Receptor-type protein-tyrosine phosphatases (RPTPs)4 are
transmembrane proteins involved in signaling pathways (1).
ICA512 (also known as IA-2, PTP35, or PTPRN) and phogrin
(also known as IA-2b, IAR, ICAAR, or PTPRN2) are R8 subtype
RPTPs mainly expressed in peptide hormone–secreting endo-
crine cells and neurons, where they are enriched in the mem-
brane of secretory granules (SGs) and large dense-core vesicles,
respectively (2, 3).
In mice, genetic deletion of ICA512, phogrin, or both results
in mild glucose intolerance and decreased glucose-responsive
insulin secretion (4 –6). A large body of evidence suggests that
both proteins are involved in the biogenesis and turnover of
insulin SGs in pancreatic islet b-cells (7–9). Accordingly, their
depletion, either alone or in combination, strongly reduces, but
does not abolish, insulin SG stores in vitro and in vivo.
ICA512 and phogrin have a large luminal ectodomain, a sin-
gle-pass transmembrane segment, and a cytoplasmic and cata-
lytically-impaired protein-tyrosine phosphatase (PTP) domain
(Fig. 1A) (10). During SG maturation, the ICA512 ectodomain
is cleaved by furin-like proprotein convertases, generating an
N-terminal fragment (ICA512 NTF; residues 35– 448) and a
transmembrane fragment (ICA512 TMF; residues 449 –979)
(3).
The cytoplasmic domain of ICA512 TMF interacts with the
cortical cytoskeleton via b2-syntrophin, an adapter protein
involved in the tethering of SGs to F-actin, thereby regulating
insulin SG mobility and exocytosis (9, 11, 12). Furthermore,
through a still unidentified signaling pathway, ICA512 modu-
lates gene expression of the F-actin modifier villin, another fac-
tor for tight control of insulin SG mobility and exocytosis (13).
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Transient insertion of ICA512 TMF in the plasma membrane
upon insulin SG exocytosis is coupled to the cleavage of its
cytoplasmic tail by Ca21-dependent calpain (12) and the gen-
eration of a cytoplasmic fragment that enhances STAT5-medi-
ated transcription of SG cargoes and mouse b-cell proliferation
(8, 11, 14, 15).
The SG luminal, N-glycosylated juxtamembrane region of
ICA512 TMF comprises the membrane-proximal ectodomain
(ICA512 MPE). X-ray crystallography revealed that ICA512
MPE is a SEA (Sea urchin sperm protein, Enterokinase, Agrin)
domain, which is compatible with its potential involvement in
cell adhesion and the formation of homo- and heterodimers
(16 –19). Further studies indicated that b-strands in ICA512
MPE promote pro-ICA512 dimerization and regulate it from
the endoplasmic reticulum (20). A similar SEA domain is also
found in the corresponding region of phogrin (21, 22).
ICA512 NTF, the other luminal segment resulting from the
proprotein convertase processing of ICA512, is much less
characterized. The ICA512 NTF region encompassing residues
35–131, immediately after the signal peptide, exhibits sequence
similarity to the regulated endocrine-specific protein 18
(Resp18; Fig. 1). As ICA512 and phogrin, Resp18 is widely
expressed in peptide hormone–secreting endocrine cells,
including a-, b-, and d-cells of the pancreatic islets, and its
expression is up-regulated in conditions stimulating SG bio-
genesis (23).
In view of its similarity to Resp18, the segment correspond-
ing to residues 35–131 of ICA512 was named Resp18 homology
domain (RESP18HD) (24). Interestingly, ICA512 RESP18HD
has a conserved cysteine-rich N-terminal region (residues
35– 62), which is absent in Resp18 (Fig. 1B).
In previous studies, we showed that ICA512 RESP18HD con-
tains sufficient information to direct green fluorescent protein
(GFP) to insulin SGs, whereas deletion of the entire ICA512
NTF, which includes ICA512 RESP18HD, causes the constitu-
tive delivery of ICA512 to the plasma membrane, hence abol-
ishing SG targeting (20, 24).
Although the detailed mechanism of proprotein sorting into
SGs is not well-established, it is clear that signal-mediated sort-
ing and congregation–aggregation of regulated cargoes con-
tribute to the biogenesis of SGs (25–28).
Congregation–aggregation processes are of two main class-
es: liquid–liquid phase transitions (LLPT) and liquid–solid
phase separation or, for short, aggregation. LLPT and aggrega-
tion have in common a stage of segregation in which the par-
ticipant molecules congregate guided by multiple noncovalent
interactions. However, the outcomes of these two processes are
different, being either separated liquid-like or solid-like phases.
These two kinds of phases establish a dynamic exchange with a
main liquid phase in which macromolecules form a nonhomo-
geneous solution.
Liquid-like phases have surface and bulk properties typical of
liquids and acquire droplet morphology (29). Typical examples
are the nucleolus, Cajal bodies, nuclear speckles, stress gran-
ules, P-bodies, and germ granules (30). Solid-like phases
result from protein aggregation that causes microscopic
solid deposition.
The morphology of solid deposits is exuberant. Crystal-like
deposits are formed in endocrine and exocrine SGs (26, 28).
Amyloids are ordered fibrillar protein deposits formed in
neurodegenerative diseases, such as Alzheimer’s, Parkinson’s,
Huntington’s, amyotrophic lateral sclerosis (ALS), Creutzfeldt-
Jakob diseases, and type 2 diabetes (29 –34) In the latter, islet
amyloid polypeptide produced by pancreatic b-cells accumu-
lates in the islets, leading to cell dysfunction, death, and insulin
deficiency. In contrast, typical amorphous aggregates in the eye
lens cause cataracts, a widespread disease of aging.
Protein congregation involves heterotropic and nonstoichio-
metric protein–protein interactions, and it is characterized by
its collective and cooperative nature. Also, it implies robust
recognition mechanisms, acting simultaneously upon very dif-
ferent proteins. In this regard, it is revealing that proteins prone
to congregation are frequently rich in intrinsically disordered
regions (IDRs) and low complexity regions, as if well-folded
proteins were less susceptible to it. Partially unfolded protein
conformations are ideal candidates for the promotion of collec-
tive congregation because they expose a higher proportion of
active areas compared with native states, thus facilitating inter-
molecular over intramolecular interactions.
Figure 1. ICA512 processing and ICA512 RESP18HD sequence. A, SG lumi-
nal segment of ICA512 (UniProtKB Q16849) comprises residues 1–575 and
includes a signal peptide (SP), the NTF, and the MPE. The transmembrane
domain (TM) comprises residues 576 – 600. The cytoplasmic region, residues
601–979, is made of the juxtamembrane intracellular domain (IC) and the
cytoplasmic cleaved fragment (CCF). Most of cytoplasmic cleaved fragment
corresponds to the pseudo-phosphatase (catalytically inactive) domain (PTP),
from which the entire protein is named. Scissors mark well-characterized pro-
cessing sites. Convertase-mediated cleavage at residue 448 generates the
transmembrane fragment (ICA512 TMF, residues 449 –979, corresponding to
MPE–TM–IC), which is transiently inserted into the plasma membrane upon
exocytosis. ICA512 RESP18HD constitutes the N-terminal portion of ICA512
NTF. B, sequence alignment of ICA512 RESP18HD, Resp18 (UniProtKB
Q5W5W9), and phogrin RESP18HD (UniProtKB Q92932). Identical residues
and cysteine residues are indicated in green and orange, respectively. An
ICA512 RESP18HD C-terminal cleavage site between Arg-124 and Asp-125 in
ICA512 RESP18HD (this work) is indicated with a down arrow. Most of the IDR
accounting for ICA512 RESP18HD aggregation activity (this work) is the prod-
uct of exon-4, which encodes for ICA512 residues 94 –126 (underlined).
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Given that cross-reactivity is an essential aspect of protein
congregation, the identification and characterization of pro-
teins that participate in congregations, and particularly of those
that may display a congregating activity, promise to be of sin-
gular importance to boost our understanding of cellular pro-
cesses, both in normal and pathological conditions. In this pres-
ent study, we investigate in greater detail the biochemical and
biophysical properties of ICA512 RESP18HD in relation to its
congregating activity.
Results
ICA512 RESP18HD aggregates and binds Zn21
The auto-aggregating activity of ICA512 RESP18HD, dem-
onstrated by light-scattering measurements (Fig. 2A), was neg-
ligible at pH 4.5, very slow at pH 6.8, and increased abruptly
above pH 7.0.
This pH dependence suggested that ICA512 RESP18HD
histidine residues (His-38, His-49, and/or His-98) might be
involved in the aggregation. Therefore, we tested possible his-
tidine ligands. Micromolar concentrations of Zn21 abolished
aggregation, and the effect was reversible by equimolar EDTA
(Fig. 2B). Neither Ca21 nor Mg21 acted like Zn21; however,
Cu21 mimicked Zn21 but with lower efficiency (Fig. S1A).
Complete inhibition of ICA512 RESP18HD self-aggregation
was observed at pH 7.4 and 15 mM Zn21 (Fig. S1B). To roughly
estimate ICA512 RESP18HD affinity for Zn21, the aggregation
kinetics was modeled as a first-order reaction, and an exponen-
tial decay was fit to the calculated rate constants (Fig. S1C). This
simplified treatment allowed Zn21 IC50 to be estimated as 2 mM.
Direct equilibrium measurements of Zn21 binding at pH 7.4
were complicated by aggregation. However, aggregation was
minimal at pH 4.5, and microfiltration through 3-kDa mem-
branes could be performed (data not shown), and by using the
law of mass action, a dissociation constant of 1 mM was calcu-
lated. This result suggests that ICA512 RESP18HD binds Zn21
even in the acidic conditions of pH 5.5 present in the lumen of
newly generated SGs (35), in which the concentration of Zn21
is '20 mM (36).
Far-UV CD spectra of ICA512 RESP18HD are shown in Fig.
S1D. The spectrum at pH 4.5 corresponded to that of a largely
unstructured peptide, and addition of 50 mM Zn21 did not
change it significantly. Both of these conditions inhibited the
aggregation of ICA512 RESP18HD.
Instead, at pH 7.4 and in the presence of 50 mM Zn21, a
condition that also inhibits ICA512 RESP18HD aggregation,
the CD spectrum evidenced two negative bands at 205 and 218
nm and one positive band at 190 nm suggestive of a-helix for-
mation. At pH 7.4 and in the absence of 50 mM Zn21, the spec-
trum taken at the onset of aggregation evidenced the same sec-
ondary structure signature. Based on these results, we
hypothesize that fully unfolded ICA512 RESP18HD has little
tendency to aggregate and that partial folding is required to
achieve an aggregation-prone state.
To better delineate the ICA512 RESP18HD residues involved
in the aggregation reaction, the variant 35–90 (RESP18HD90)
was prepared. This variant contains the N-terminal Cys-rich
motif (residues 35– 61) but lacks the IDR encompassing resi-
dues 91–131 (see below). ICA512 RESP18HD90 did not aggre-
gate under any of the conditions tested above (data not shown).
ICA512 RESP18HD–insulin aggregation
Unless otherwise indicated, the results reported in this sec-
tion are from experiments conducted in incubation media con-
taining 2 mM ICA512 RESP18HD and 8 mM insulin.
At pH 6.8, neither insulin nor ICA512 RESP18HD formed
higher-order aggregates in isolation. However, when incubated
together, ICA512 RESP18HD and insulin formed aggregates,
readily detectable by light scattering (Fig. 2C). ICA512
RESP18HD90 did not aggregate with insulin (data not shown)
and neither ICA512 RESP18HD nor insulin aggregated at pH
4.5 (Fig. 2D).
Zn21 inhibited the self-aggregation of ICA512 RESP18HD at
pH 7.4 (Fig. 2B), but it did not inhibit the coaggregation of
insulin and ICA512 RESP18HD at pH 6.8 (Fig. 2E). Thus, the
aggregation of ICA512 RESP18HD with insulin is not a conse-
quence of previous aggregation of ICA512 RESP18HD. Because
Ca21 is present at high concentrations in the SGs, its effects in
the aggregation reactions was also investigated. Ca21 did not
inhibit the self-aggregation of ICA512 RESP18HD at pH
7.4 (Fig. S1A) or the coaggregation of insulin and ICA512
RESP18HD at pH 6.8 (Fig. 2E).
To investigate whether the observed aggregation of ICA512
RESP18HD with insulin at pH 6.8 could result from ICA512
RESP18HD removal of Zn21 from insulin, it was verified that
EDTA did not induce insulin aggregation (Fig. 2C).
Aggregates formed by coincubation of ICA512 RESP18HD
and insulin at pH 6.8 dissolved at pH 4.0 (Fig. 2F). Moreover,
aggregation was not influenced by reducing agents like DTT,
phosphine, or mercaptoethanol (data not shown), suggesting
that thiol– disulfide exchange reactions were not involved in
the process.
ICA512 RESP18HD–insulin aggregation at pH 6.8 was com-
pletely blocked by preincubation with 100 mM L-arginine (data
not shown). L-Arginine is an unspecific anti-aggregating agent
employed in protein folding protocols (37). L-Arginine added
when aggregation was in progress prevented further aggrega-
tion, but already formed aggregates did not dissolve.
ICA512 RESP18HD was also assayed for aggregation at pH
6.8 in the presence of proinsulin (His6) and amylin. Proinsulin
behaved similarly to insulin (data not shown). Amylin was neg-
ative in the reaction with ICA512 RESP18HD but acted as
a potent inhibitor in the aggregation of the pair ICA512
RESP18HD–insulin (Fig. 2G). This activity of amylin suggests
that it interacts with either ICA512 RESP18HD, insulin, or with
their complex blocking aggregation. Interestingly, an insulin
anti-aggregating activity of amylin has been reported before
(38).
In SGs, insulin is present mostly as a crystalline condensate
and at concentrations as high as 30 mM (39). The concentration
of soluble insulin potentially able to coaggregate with ICA512
RESP18HD is not known, but it could be higher than that
assayed in the above experiments (8 mM). Therefore, the aggre-
gation reaction was also tested at 2 mM ICA512 RESP18HD and
400 mM insulin. Aggregation was strongly inhibited under this
condition (data not shown).
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The aggregate and soluble fractions from ICA512 RESP18HD–
insulin incubates could be easily separated by centrifugation at
13,000 rpm. The recovery of significant amounts of both pro-
teins in the pellet demonstrated that ICA512 RESP18HD
and insulin coaggregate when incubated together at pH 6.8
(Fig. 3A). In contrast, ICA512 RESP18HD90 did not coaggre-
gate with insulin, as both proteins were not recovered together
in the pellet (Fig. 3A).
Separation of pellets and supernatants followed by SDS-
PAGE and band quantification established the proportion of
each protein in the aggregate for different concentration ratios
of ICA512 RESP18HD/insulin in the incubation media (Figs. S2
and S3 and Methods S1). In excess of insulin, as likely occurs in
cells, coincubation produced an aggregate with 2.8 mol of
insulin/mol of ICA512 RESP18HD. In excess of ICA512
RESP18HD, the proportion was 0.4 mol of insulin/mol of
ICA512 RESP18HD.
The variable proportion of each component suggests that the
aggregate is formed by a solid-phase condensation mechanism,
influenced by the relative concentrations of the interacting par-
ticles, which is different from specific mechanisms of aggrega-
tion involving constant stoichiometric relationships.
The effect of Zn21 on the coaggregation reaction was further
assessed by centrifugation and SDS-PAGE analysis (Fig. S4).
This analysis indicated that at low concentrations Zn21 does
not inhibit the coaggregation, corroborating the above results
obtained by light-scattering measurements (Fig. 2E). However,
100 mM Zn21 had a moderate inhibitory effect on the incorpo-
ration of ICA512 RESP18HD in the coaggregate.
Temperature dependence of the aggregation
ICA512 RESP18HD self-aggregation and ICA512 RESP18HD–
insulin coaggregation were tested at different temperatures in
the 5– 40 °C range. Aggregation velocities increased smoothly
with temperature (data not shown), as expected for typical col-
lisional mechanisms. In a typical LLPT, for a given protein con-
centration, there is a critical temperature above which a single
homogeneous phase exists (40). Such critical temperatures
could not be detected at the protein concentrations assayed in
this work. The absence of a temperature-dependent cutoff in
the aggregation reactions of ICA512 RESP18HD is compatible
with solid–liquid phase separations, as those that result in
microscopic deposits of amorphous aggregates or the forma-
tion of amyloid fibers.
Thioflavin T (ThT) is a highly-specific probe for protein
fibrillation because its fluorescence increases several orders
of magnitude upon binding to the cross-b-structure of amyloid
fibrils. ICA512 RESP18HD self-aggregates and ICA512
RESP18HD–insulin coaggregates formed at 20 °C tested neg-
ative in a ThT fluorescence assay for cross-b-fibrils (data not
Figure 3. Isolation of ICA512 RESP18HD aggregates. The aggregation
reaction was conducted as described in Fig. 2. Pellets (P) and supernatants (S)
obtained by centrifugation from the sample incubates were loaded quanti-
tatively into the SDS-PAGE lanes. A, co-incubation of insulin (8 mM) and ICA512
RESP18HD (2 mM) results in a pellet containing both proteins. ICA512
RESP18HD90 does not coaggregate with insulin, and therefore both proteins
are recovered only in the supernatant. Control lanes indicate that none of the
proteins aggregate in isolation. B, ICA512 RESP18HD (2 mM) does not coag-
gregate with myoglobin, staphylococcal nuclease, or RNase A (8 mM). These
well-characterized, soluble proteins, along with ICA512 RESP18HD, are recov-
ered in the soluble fractions (S). Centrifugation was omitted in control incu-
bates (I). C, ICA512 RESP18HD (2 mM) exhibits a broad coaggregating activity
upon a pancreas homogenate (Hmg). ICA512 RESP18HD90 lacks such activity.
Figure 2. Time-course aggregation of ICA512 RESP18HD. The reaction was monitored by the increment of absorbance (light scattering) at 400 nm. A and
B, reaction was initiated by adding ICA512 RESP18HD to the reaction buffer at 2 mM final concentration. C–G, reaction was initiated by adding insulin 8 to 2 mM
to ICA512 RESP18HD solutions. Arrows mark the time of reagent addition. A, ICA512 RESP18HD aggregation is negligible at pH 4.5, barely detectable at pH 6.8,
and very rapid at pH 7.4. B, Zn21 inhibits aggregation of ICA512 RESP18HD at pH 7.4, an effect that is reversed by equimolar EDTA. C, incubation of ICA512
RESP18HD and insulin at pH 6.8 (solid line) results in aggregation. Insulin (dashed line) or ICA512 RESP18HD (dotted line) alone do not aggregate separately. The
2nd arrow in the insulin trace marks the addition of 12.5 mM EDTA. D, neither insulin alone (dashes), ICA512 RESP18HD alone (dots), nor in combination (solid line)
aggregate at pH 4.5. E, aggregation reaction of insulin and ICA512 RESP18HD at pH 6.8 (solid line) is unaffected by 50 mM Zn21 (dashed line) or 50 mM Ca21 (dotted
line). F, aggregation at pH 6.8 is reversed by acidification to pH 4.0 with HCl (dashed line; arrow at 400 s). Adding equivalent concentrations of NaCl instead of
HCl stops further aggregation but does not dissolve preexistent aggregates (solid line). G, amylin inhibits ICA512 RESP18HD–insulin aggregation. The reaction
was performed in the absence of amylin (solid black line) and with 8 mM amylin (dashed black line). ICA512 RESP18HD is required for aggregation because neither
8 mM insulin 1 8 mM amylin (solid gray line), 2 mM ICA512 RESP18HD 1 8 mM amylin (dashed gray line), 8 mM amylin (solid light gray line), 2 mM ICA512 RESP18HD
(dashed light gray line), nor 8 mM insulin (dotted light gray line) aggregate in the assay. H, ThT fluorescence assay for insulin fibrillation. Fibrillation was performed
at 60 °C with stirring (see “Experimental procedures”). The composition of the sample incubates is indicated at the bottom. Error bars indicate the standard
deviation of three independent experiments.
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shown), corroborating that the solid deposits were of amor-
phous nature.
Inhibition of insulin fibrillation
Insulin submitted to high temperatures, stirring, or agitation
converts into amyloid cross-b-fibrils (41). To test the possibility
that ICA512 RESP18HD could affect the fibrillation of insulin, a
fibrillation assay was set up in which insulin solutions were
subjected to physical stress by incubation at 60 °C under
stirring.
As expected, stressed insulin solutions yielded a strong ThT
fluorescent signal. In the presence of either ICA512 RESP18HD
or ICA512 RESP18HD90, ThT fluorescence was negligible,
indicating that insulin fibrillation was abolished (Fig. 2H). Nei-
ther of the two ICA512 RESP18HD variants fibrillated on their
own account (data not shown). These results imply that resi-
dues 35–90 of ICA512 RESP18HD bind to insulin and impede
its fibrillation.
ICA512 RESP18HD possesses broad protein-condensing
activity
To evaluate the specificity of the reaction, several pure, well-
characterized, and highly-soluble proteins were incubated with
ICA512 RESP18HD under conditions similar to those used in
the aggregation tests with insulin, and the pellets obtained by
centrifugation were analyzed by SDS-PAGE. The results for
myoglobin, staphylococcal nuclease, and RNase are shown in
Fig. 3B. Similar results were obtained with lysozyme and human
serum albumin (data not shown). Altogether, these results indi-
cate that ICA512 RESP18HD has no condensing activity toward
these isolated highly-soluble proteins.
Next, we asked whether the condensing activity of ICA512
RESP18HD was preferentially directed to particular proteins in
a complex mixture. To that end, the reaction was set up as
above but replacing pure proteins by cell homogenates. The
result with a rat pancreas homogenate is shown in Fig. 3C. In
the absence of ICA512 RESP18HD, few proteins and in trace
amounts were recovered in the pellet (Fig. 3C, 5th lane). Adding
ICA512 RESP18HD to the incubation mixture had a large effect
on the reaction; nearly all proteins in the homogenate appeared
with substantial yield in the pellet (compare 7th and 8th lanes
with 5th and 6th lanes in Fig. 3C). Interestingly, ICA512
RESP18HD90 did not aggregate proteins from the pancreas
homogenate (Fig. 3C, 9th and 10th lanes). Because ICA512
RESP18HD90 did not aggregate insulin (Fig. 3A), it can be
inferred that the aggregating activity of ICA512 RESP18HD
requires residues 91–131.
A density image analysis of the homogenate coprecipitation
illustrates further the remarkable condensing activity of
ICA512 RESP18HD (Fig. S5); in most cases, at least half of each
protein band was recovered in the pellet fraction, as well as
nearly all ICA512 RESP18HD.
Interestingly, pure insulin added to the lysate was recovered
in the pellet with low yield (Fig. S5). Thus, the affinity of ICA512
RESP18HD for insulin was counterbalanced by the competition
for homogenate proteins that were in huge excess. Similar
results were obtained with Saccharomyces cerevisiae and liver
homogenates (data not shown).
Human EndoC–bH1 cells constitute an excellent experi-
mental model to study insulin secretion (42). Therefore, the
coaggregating activity of ICA512 RESP18HD was assayed with
homogenates of these cells, and the results are shown in Fig. 4.
ICA512 RESP18HD broadly coaggregated with EndoC–bH1
cell proteins (Fig. 4, lanes 3 and 4), similarly to what was
described above with other cell homogenates. Insulin per se did
Figure 4. Coaggregation reaction of ICA512 RESP18HD and human EndoC–bH1 cell proteins. Two-layer SDS-PAGE separating gels were used in the
analysis (10 and 17% acrylamide, top and bottom, respectively). The boundary between the layers is marked with a double-headed arrow. Fixed amounts of
EndoC–bH1 homogenate were incubated with the indicated concentrations of ICA512 RESP18HD and insulin. The incubation mixture was processed as
described in Fig. 3 to separate pellet (P) and soluble (S) fractions. Lanes 1 and 2, incubation of equimolar concentrations of insulin and ICA512 RESP18HD in the
absence of EndoC–bH1 proteins results in coaggregation and recovery of most of both proteins in the pellet. Slow formation of covalently-linked multimers
occurs spontaneously in ICA512 RESP18HD solutions (24). Here, however, this tendency was exacerbated by the coincubation with insulin. Lanes 3 and 4,
ICA512 RESP18HD coaggregates with EndoC–bH1 proteins in the absence of added insulin. Lanes 5–10, ICA512 RESP18HD coaggregates with added insulin and
EndoC–bH1 proteins. However, a 5-fold excess of insulin over ICA512 RESP18HD decreases the yield of insulin in the coaggregate. Lanes 11 and 12, insulin per
se has no aggregating activity on the protein homogenate.
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not coaggregate proteins in EndoC–bH1 cell homogenates
(Fig. 4, 11th and 12th lanes). When in combination, ICA512
RESP18HD and insulin coaggregated along with the homoge-
nate (Fig. 4, 5th and 10th lanes). However, the yield of insulin in
the coaggregate varied, with most insulin being recovered in the
supernatant, as also observed with rat pancreas homogenates
(Fig. S5).
ICA512 RESP18HD–insulin condensates characterized by TEM
TEM analysis confirmed the amorphous nature of both
ICA512 RESP18HD and ICA512 RESP18HD–insulin aggre-
gates and the lack of fibers and regularly packed particles (Fig.
5). This result is coherent with the lack of fixed stoichiometry in
the formation of the segregated solid phase described above.
ICA512 RESP18HD–insulin preparations showed denser
aggregates than in the case of samples containing ICA512
RESP18HD alone.
Residues 91–131 of ICA512 RESP18HD constitute an IDR
As mentioned above, ICA512 RESP18HD90 was unable to
coaggregate with insulin or with other proteins in pancreas
homogenates. Therefore, it was inferred that the condensing
activity of ICA512 RESP18HD requires residues 91–131. Using
the sequence-based disorder prediction servers, PONDR VSL2
(http://www.pondr.com/5 (43)), IUPRED, and ANCHOR
(http://iupred2a.elte.hu/5 (44)), residues 91–131 of ICA512
RESP18HD were identified as an IDR. This sequence region is
enriched in arginine and proline residues (Fig. 1B), a typical
signature of structural disorder.
Interestingly, the IDR segment of ICA512 RESP18HD is part
of the larger predicted IDR regions within ICA512 NTF (resi-
dues 109 –176, 283–341, and 370 – 465; Fig. 1A), which open
the possibility that most of ICA512 NTF could be involved in
condensing processes.
ICA512 RESP18HD antibody staining in cells and islets
We reported previously that the C-terminally GFP-tagged
ICA512 RESP18HD (residues 1–131) is targeted to insulin SGs,
showing that ICA512 N-terminal domain contains sufficient
information for SG localization in b-cell like INS-1 cells (20).
For the current analyses, we transfected INS-1 cells with new
constructs in which the GFP tag was replaced by its derivative
Turquoise 2 (TQ2), TQ2 behaves essentially as GFP but is pH-
insensitive and less prone to aggregation.
Also for these analyses, we generated a novel mouse mono-
clonal ICA512 RESP18HD antibody. Because ICA512 RESP18HD
shares sequence homology with phogrin and Resp18 (Fig. 1B),
we verified the specificity of this new antibody. To this end,
INS-1 cells were transfected with human ICA512 RESP18HD–
TQ2 (residues 1–131), Phogrin RESP18HD–TQ2 (residues
1–136), or Resp18 –TQ2 (Resp18 residues 1–228) fusion pro-
teins. INS-1 cells expressing the constructs were analyzed by
immunoblotting, with either mouse anti-GFP (for the TQ2 tag)
or the novel anti-ICA512 RESP18HD antibodies (Fig. 6A).
As expected, ICA512 RESP18HD–TQ2 was detected with
both the anti-GFP and the anti-ICA512 RESP18HD antibodies,
mainly as the intact fusion protein of '40 kDa (Fig. 6A, 1st
lane). Phogrin RESP18HD–TQ2 and Resp18 –TQ2 were also
recognized, mainly as intact fusions, by the anti-GFP antibody
but not by the anti-ICA512-RESP18HD antibody (Fig. 6A, 2nd
and 3rd lanes), demonstrating the specificity of the latter for
ICA512. Further immunoblotting analysis using C-terminal
deletion and site-specific mutants established that the novel
antibody recognizes a C-terminal epitope encompassing resi-
due 125 of ICA512 RESP18HD (Fig. S6).
Next, the anti-ICA512 RESP18HD antibody was tested for
detection of endogenous RESP18HD in human pancreatic tis-
sue sections and human EndoC–bH1 cells by immunofluores-
cence microscopy. The anti-ICA512 RESP18HD antibody sig-
nal was enriched in the endocrine cells and islets, where it
overlapped with the signal for insulin (Fig. 6B). As expected, in
EndoC–bH1 cells, the immunofluorescence signal for ICA512
RESP18HD colocalized with the punctated insulin-positive
structures (Fig. 6C). Finally, the specificity of the anti-ICA512
RESP18HD antibody was further corroborated by immuno-
blotting of human EndoC–bH1 cell lysates depleted of ICA512
by RNAi (Fig. S7).
ICA512 RESP18HD is processed upon regulated secretion
Next, we exploited the novel anti-ICA512 RESP18HD anti-
body to investigate the processing and putative secretion of
ICA512 RESP18HD and variants thereof. To this aim, WT and
ICA512 RESP18HD–TQ2-transfected INS-1 cells were cul-
tured in resting or glucose-stimulated conditions, and the cell
5 Please note that the JBC is not responsible for the long-term archiving and
maintenance of this site or any other third party hosted site.
Figure 5. TEM of ICA512 RESP18HD and ICA512 RESP18HD–insulin
aggregates. The aggregate of ICA512 RESP18HD and the coaggregate of
ICA512 RESP18HD and insulin at pH 6.8 were prepared for negative staining.
A, overview of ICA512 RESP18HD aggregates alone with higher magnification
of the enclosed areas in B. C and D, low- and high-magnification images for
ICA512 RESP18HD together with insulin. In both cases, the aggregate is of an
amorphous nature and lacks periodic fibrils. The sponge-like matrix formed is
thinner and more porous in the ICA512 RESP18HD alone aggregation. Scale
bars, A and C, 60 nm; B and D, 30 nm.
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lysates and the immunoprecipitates from the corresponding
culture media were subjected to immunoblotting analysis (Fig.
7, A and B, respectively).
In resting and stimulated INS-1 cells, full-length “mature”
ICA512 RESP18HD–TQ2 was detected by anti-GFP and anti-
ICA512 RESP18HD antibodies as a band of '40 kDa (Fig. 7A,
asterisks). In resting cells, the anti-GFP antibody detected also a
faint band .40 kDa, indicating the presence of pro-ICA512
RESP18HD–TQ2 species, which conceivably still contained the
signal peptide. Mature ICA512 RESP18HD–TQ2 detected with
both antibodies was more abundant in resting than in stimu-
lated cells, which is compatible with its secretion upon glucose
stimulation.
In resting, but not in stimulated, cells the anti-GFP antibody
recognized an ICA512 RESP18HD–TQ2 proteolytic fragment
of '30 kDa (Fig. 7A, arrowhead). This fragment corresponds to
TQ2 preceded by a short sequence from the C terminus of
ICA512–RESP18HD. Its absence in stimulated cells suggests
that it may be exported along with the mature form upon
stimulation.
Another proteolytic fragment of '27 kDa compatible with
the bare size of TQ2 was detected in resting and stimulated cells
(Fig. 7A, double arrowheads). The fact that this fragment was
not depleted in stimulated cells is an indication that it may be
not secreted, as often observed for cytosolic GFP/TQ2 remain-
ing after incomplete proteasomal degradation of fusion pro-
teins (Ref. 45 and references therein).
Remarkably, in the culture media, the 40-kDa mature
ICA512 RESP18HD–TQ2 was present in significant amounts
only with stimulated cells (Fig. 7B, asterisks), which were also
enriched for the presence of a single '30-kDa fragment (Fig.
7B, arrowhead). The abundant recovery of both ICA512
RESP18HD–TQ2 species in the culture media of glucose-stim-
ulated cells suggests that the 40-kDa fragment is secreted in a
regulated fashion and converted to the 30-kDa species by
proteolysis.
ICA512 RESP18HD–processing site
Immunoprecipitates from culture media of glucose-stimu-
lated INS-1 cells expressing ICA512 RESP18HD–TQ2 were
run on SDS-PAGE, and the isolated '30-kDa band was sub-
jected to “in gel” digestion with trypsin and MS analysis.
Observed peptide masses and fragmentation patterns (data
not shown) identified (a) several peptides corresponding to the
inner sequence of TQ2 and (b) two N-terminally extended
peptides with the sequence “DRSGLAPGPVATMVS” and
“SGLAPGPVATMVSK,” respectively. In these two peptides,
“DRSGLAP” and “SGLAP”’ map to the C terminus of ICA512
RESP18HD (see also Fig. 1B; residues 125–131, and 127–131,
respectively); “GPVAT” corresponds to a linker sequence
between ICA512 RESP18HD and TQ2, and “MVSK” is from the
N terminus of TQ2. The shorter peptide is likely the result of
the trypsin digestion applied. Because the single '30-kDa frag-
ment reacted with the anti-ICA512 RESP18HD antibody (Fig.
7A, arrowhead), which detects an epitope, including residue
125 (see also Fig. S6), it is concluded that the processing site
locates close to residue 125 (see Fig. 1B) and within the IDR of
ICA512 RESP18HD. Because of limitations of the ICA512
RESP18HD antibody, epitope recognition and also other
potential peptide recognition by the MS analysis, we cannot
completely exclude the presence of other proteolytic sites
beyond Asp-125.
Discussion
Our finding that ICA512 RESP18HD possesses in vitro pro-
tein-condensing activity turns it into a potentially important
factor for SG biogenesis and regulated secretion. In this regard,
ICA512 RESP18HD resembles other luminal domains of SG
membrane proteins, including dopamine b-hydroxylase, pepti-
dyl glycine a-amidating enzyme, carboxypeptidase E, and gra-
nin, which have been reported to coaggregate with SG cargoes
proteins (Ref. 46 and references therein). Interestingly, these
condensing factors aggregate at the acidic pH of mature SGs,
whereas ICA512 RESP18HD displays condensing activity at pH
close to neutral, with acidic pH inhibiting its self-aggregation or
coaggregation with insulin. Hence, ICA512 RESP18HD likely
exerts its condensing activity at early stages of granulogenesis
along the secretory pathway, i.e. prior to that of other granule
cargoes.
The coaggregation of ICA512 RESP18HD and insulin takes
place at very low protein concentrations, under pH and tem-
perature conditions close to physiological, and with no external
Figure 6. Immunostaining with the anti-ICA512 RESP18HD antibody. A,
rat INS-1 cells transfected with constructs expressing C-terminal TQ2 fusion
proteins of human ICA512 RESP18HD (residues 1–131), phogrin RESP18HD
(residues 1–136), or Resp18 (residues 1–228) cells were lysed and analyzed by
SDS-PAGE and immunoblotting, using for detection either mouse anti-GFP
(that cross-reacts with TQ2) or mouse anti-ICA512 RESP18HD antibodies. All
intact TQ2 fusion proteins were detected by the mouse anti-GFP antibody,
whereas the mouse anti-ICA512 RESP18HD antibody only recognized ICA512
RESP18HD–TQ2. B, immunostaining of human pancreatic tissue sections. C,
human EndoC–bH1 cells with guinea pig anti-insulin and mouse anti-ICA512
RESP18HD antibodies. Insulin and ICA512 RESP18HD signals were found
restricted to the islets with a punctated signal consistent with SGs labeling (B
and C). Scale bars, 20 mm; ab, antibody.
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physical stress (shearing, stirring, or heating). Under these con-
ditions, isolated ICA512 RESP18HD and insulin per se do not
aggregate appreciably and exhibit a moderate and low degree of
oligomerization, respectively (24, 47). Thus, proper conditions
for coaggregation of insulin and ICA512 RESP18HD are likely
to evolve in vivo.
Another important finding is that Zn21 does not inhibit
ICA512 RESP18HD–insulin coaggregation (Fig. 2E). Because
Zn21 inhibits the homophilic aggregation of ICA512 RESP18HD
at neutral pH (Fig. 2B), the lack of effect on the coaggregation
with insulin suggests that the reaction is not triggered by pre-
viously formed aggregates of ICA512 RESP18HD and, on the
contrary, is caused by the interaction of soluble ICA512
RESP18HD and insulin. This behavior also suggests that coag-
gregation would not be impeded by the high concentrations of
Zn21 present in the SG of b-cells. However, the coaggregation
of ICA512 RESP18HD and insulin may be resolved upon their
exposure to the very acidic pH of mature SGs (Fig. 2, D and F).
Moreover, the observation that amylin inhibits the coaggrega-
tion of ICA512 RESP18HD and insulin (Fig. 2G) reinforces the
idea of an interaction between two soluble partners that results
in mutual insolubility, for amylin is known to interact directly
with soluble insulin and impair its aggregation (38).
Several stable, soluble, and well-characterized proteins were
shown to coaggregate if incubated at their melting temperature.
This indicates that partially folded states are involved in coag-
gregation (48). ICA512 RESP18HD is known to be partially
unfolded under our experimental conditions. Insulin, in con-
trast, is monomeric and folded. However, monomeric insulin is
less stable than hexameric insulin and has a greater tendency to
populate partially folded states (49). Thus, if coaggregation of
ICA512 RESP18HD and insulin requires two partially unfolded
partners, ICA512 RESP18HD might act shifting the equilib-
rium of monomeric insulin toward a partially folded state.
Our findings buttress the idea that one of the main mecha-
nisms involved in targeting and regulated secretion is the con-
gregation of mutually interacting proteins in aggregated phases
(26, 28). However, because of the complexity of the machinery
for granule biogenesis, the multiplicity of players, and their
redundancy, an essential role of ICA512 RESP18HD is unlikely.
Proof of this is shown in mice with genetic deletion of ICA512
and phogrin, two proteins with a RESP18 domain, and SG
stores are reduced but not abolished (6).
It is possible that the properties of ICA512 RESP18HD are
modulated through interactions with the remaining ICA512
NTF sequence. Unfortunately, pure recombinant variants of
the entire NTF domain (Fig. 1A) could not be prepared due to
expression and solubility difficulties (data not shown), which
impeded in vitro assessment of this possibility. In vivo assays,
however, are tedious due to the complexity of post-transla-
tional processing of the NTF domain, including its proteolytic
cleavage and O-glycosylation.6 Moreover, the IDR region in
ICA512 RESP18HD is part of larger IDR regions in the ICA512
NTF, which might have a bearing in the aggregation behavior of
the ICA512 TMF as a whole. However, the ICA512 RESP18HD
sequence by itself contains sufficient information to direct GFP
and its variants to insulin SGs (20, 24, 35), which justify using
the information gathered studying ICA512 RESP18HD as a
guide for the further characterization of ICA512 NTF in the
cellular context.
Coaggregation of ICA512 RESP18HD–insulin in vitro occurs
within a few minutes and under very mild conditions, and
therefore it is different from typical insulin fibrillation or amy-
loidogenic reactions, which take days and require physical
stress. However, partially folded states and aggregates can
evolve toward highly-stable cross-b-fibrils, and this process is
at the core of several misfolding diseases and attracts enormous
interest from a practical and theoretical point of view (50).
For its availability in pure form and large quantities, and its
tendency to form cross-b-structure in vitro, insulin is a popular
experimental model for the study of fibrillogenesis. Even
though insulin fibrils have not been directly linked to any mis-
folding disease, they have been associated with problems in the
manufacturing, storing, and administration of insulin (50, 51).
In addition, cytotoxic effects of insulin fibrils have been
reported in cell cultures (52), thereby opening the possibility
that yet to be discovered misfolding disorders directly due to
insulin fibrillation might exist.
Predictably, biophysical studies found that insulin fibrillo-
genesis has much in common with the amyloidogenesis of sev-
eral proteins associated with misfolding pathologies. The coin-
cidences arise because fibrillation and amyloidogenesis are
manifestations of protein folding, a fundamental process in
6 J. M. Torkko, P. L. Toledo, M. R. Ermácora, and M. Solimena, unpublished
observations.
Figure 7. ICA512 RESP18HD–TQ2 processing in INS-1 cells. Resting (R) and glucose stimulated (S) conditions were assayed. Immunoblotting was performed
using mouse anti-GFP or anti-ICA512 RESP18HD antibodies. A, cell lysates. B, culture media proteins immunoprecipitated with a goat anti-GFP antibody. The
amount of ICA512 RESP18HD–TQ2 ('40 kDa; asterisks) was reduced in stimulated compared with resting cells. The opposite applied to media immunopre-
cipitates. This behavior is consistent with regulated secretion of ICA512 RESP18HD–TQ2. Remarkably, a single fragment of '30 kDa (arrowhead) comprising a
short C-terminal sequence of ICA512 RESP18HD preceding TQ2 was highly enriched in the culture media from stimulated cells, implying that the proteolysis
of the intact 40-kDa fragment is coupled to its secretion. Other proteolytic fragments of '27 kDa (double arrowheads) did not react with the anti-ICA512
RESP18HD antibody (ab).
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biology. For fibrillation to occur, conformational changes must
take place, such as the backbone adoption of b-structure and its
association into regular b-sheets perpendicular to the fibril’s
long axis.
Ligands interacting with the fibrillation nucleus or with
protofibrils may block the formation of cross-b-structure.
Driven by the need of therapeutic agents for amyloidosis, sev-
eral chemical compounds, peptides, and proteins have been
discovered with the potential to stop the progression or even
revert fibrillation processes (53).
The discovery in this work that the interaction between
ICA512 RESP18HD and insulin results in amorphous coaggre-
gation prompted us to test whether ICA512 RESP18HD fibril-
lates itself and whether it can induce the fibrillation of insulin.
Unexpectedly, not only ICA512 RESP18HD was unable to
fibrillate itself but was also a strong inhibitor of the fibrillation
of insulin. These effects were recapitulated with ICA512
RESP18HD90, suggesting that the N-terminal segment of
ICA512 RESP18HD is responsible for this inhibition. Because
ICA512 RESP18HD90 lacks the C-terminal IDR and does not
aggregate per se, its previous aggregation is dispensable for inhi-
bition of insulin fibrillation.
Two previously proposed mechanisms for the inhibition of
insulin fibrillation are (a) binding of the inhibitor to a fibrilla-
tion-competent partially folded insulin monomer, and (b)
direct binding of the inhibitor to the growing fibrils (49). Fur-
ther studies are needed to define which of these alternatives
applies to ICA512 RESP18HD inhibition.
Insulin fibrils, or precursors thereof, have been proposed to
affect b-cells and insulin secretion and circulation. Thus, pre-
sumably, an efficient control mechanism keeps in check the
insulin fibrillation. This presumption is further sustained by
the fact that, despite the high concentrations of insulin in
b-cells and the easiness of insulin fibrillation in vitro, no pathol-
ogies directly associated to insulin fibrillation have ever been
reported.
A very strong inhibitor of insulin fibrillation could be the very
high intragranular concentration of insulin, which, along with
the high concentration of Zn21, stabilizes the hexameric
insulin–Zn21 complex and reduces the concentration of aggre-
gation-prone monomeric insulin.
Amylin, which is present at high concentrations in the SG,
may also be a natural inhibitor of insulin aggregation and fibril-
logenesis (54, 55). Also, a ubiquitous Ca21-binding protein,
nucleobindin-1, similar to calreticulin, was found to inhibit
insulin fibrillation, attenuate fibril-induced cell toxicity, and is
proposed to act as an insulin chaperone in the control of amy-
loidogenesis in type 2 diabetes (56).
Moreover, we found that exocytosis of ICA512 RESP18HD is
coupled with the proteolysis of its C-terminal IDR. Because this
is the region responsible for the condensing activity of ICA512
RESP18HD at pH .7.0, it is tempting to propose that such
cleavage is required for preventing detrimental consequences
resulting from the aggregation of the protein upon its secretion
in the extracellular compartment. The identification of the pro-
tease responsible for ICA512 RESP18 HD IDR cleavage and the
regulation of this process shall be the topic of future studies.
In conclusion, given the multiplicity of proteins and peptides
that interact in the SG, it can be hypothesized that the control
mechanism to prevent amyloidogenesis is based in a web of
interactions between granular cargo and constitutive proteins.
In the context of this complex anti-amyloidogenesis system,
ICA512 RESP18HD may play an important role due to its
preferential interaction with insulin. However, new in vivo
experimental approaches need to be devised to confirm this
possibility.
Experimental procedures
Antibodies, chemicals, and general protocols
Chemicals were of the purest analytical grade available.
Human insulin was a gift from Dr. Nestor Annibali (Denver
Farma, Buenos Aires, Argentina) and also purchased from
Sigma (91077C). Recombinant human proinsulin extended
with N-terminal Met, His6 tag, and Lys was from R&D Systems
(1336-PN). Thioflavin T was from Sigma (T3516).
The novel mouse mAb against human ICA512 RESP18HD
was raised with the MPI-CBG antibody facility (Dresden, Ger-
many). Mouse and goat anti-GFP, guinea pig anti-insulin, as
well as human anti-ME ICA512 antibodies were described pre-
viously (20).
In some experiments, to achieve good resolution in a wide
range of molecular weights, SDS-polyacrylamide gels were pre-
pared with two consecutive separating layers of 10 and 17%
acrylamide, respectively.
ICA512 RESP18HD concentration was measured using an
absorption coefficient at 280 nm of 7,450 M21 cm21 (24). Bind-
ing of Zn21 to ICA512 RESP18HD was assessed by filtration
through microfilters at a 3-kDa cutoff. Zn21 concentration was
determined colorimetrically, following the formation of a com-
plex with Zincon (SC-25839 Santa Cruz Biotechnology).
CD spectra were collected at 20 °C on a Jasco 810 spectropo-
larimeter (Jasco Corp., Tokyo, Japan) as described (57). Steady-
state fluorescence measurements were performed on an ISS
K2 multifrequency phase fluorometer (ISS, Champaign, IL)
equipped with a cell holder connected to a circulating water
bath at 20 °C and with 1.0-cm cells.
In-gel trypsin digestion of SDS-PAGE excised bands was per-
formed with an In-Gel tryptic digestion kit (Thermo Fisher Sci-
entific). Recovered peptides were subjected to LC-MS/MS with
electrospray ionization in an LTQ Orbitrap XL ETD instru-
ment (Thermo Fisher Scientific).
Microscopy images of human EndoC–bH1 cells and pancre-
atic islet sections were acquired with an Olympus FluoView-
1000 laser-scanning confocal microscope equipped with a 60
PlanoApo OLSM lens (numerical aperture 1.10) (MPI-CBG,
Dresden, Germany). SDS-PAGE image analysis was carried out
with ImageJ.
DNA constructs and protein expression
The pET-9 plasmid for expression of human ICA512
RESP18HD in E. coli was described previously (24). A truncated
variant ICA512 RESP18HD90 (residues 35–90) was generated
by site-directed mutagenesis (QuikChange, Stratagene) by
replacing the codon for residue 91 with a stop codon. Purifica-
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tion of ICA512 RESP18HD was previously described (24). A
similar protocol was used to purify ICA512 RESP18HD90.
For expression in INS-1 cells, cDNAs encoding ICA512
N-terminal signal peptide sequence and either full (residues
1–131) or a truncated variant of ICA512 RESP18HD (residues
1–124) was generated by PCR and fused in-frame to a sequence
encoding TQ2 at their C termini. TQ2 is a derivative of GFP,
and ICA512 RESP18HD–GFP was assessed in our previous
work (20). Similarly the cDNAs encoding for both human pho-
grin ICA512 RESP18HD (residues 1–136) and human Resp18
(residues 1–228) were generated by PCR and fused at their
C termini to TQ2. All constructs were verified by DNA
sequencing.
Cell culture and immunocytochemistry
Cultures of INS-1 insulinoma cells and their exposure to
resting and high-glucose stimulation (cell lysate preparation,
and culture media immunoprecipitation) were performed as
described (20). To harvest resting and stimulation culture
media, these were at first pipetted from the cells into 15-ml
Falcon tubes, inclusive protease inhibitors (1:100; Sigma), cen-
trifuged briefly to clear the media fractions from any residual
cells, and prepared for immunoprecipitation using goat anti-
GFP antibody essentially as described (20). Human EndoC–
bH1 cells were cultured in Dulbecco’s modified Eagle’s medium
with 5.5 mM glucose, 2% BSA Fraction V, 50 mM 2-mercapto-
ethanol, 10 mM nicotinamide, 5.5 mg/ml transferrin, 6.7 ng/ml
selenite, 100 units/ml penicillin, and 100 mg/ml streptomycin.
EndoC–bH1 cell lysates were prepared in 50 mM HEPES, pH
7.0. EndoC–bH1 cell transfections with esiRNA (Eupheria Bio-
tech, Dresden, Germany) were performed with DharmafectTM
transfection reagents. Paraffin sections of human pancreatic
islets were prepared as described (58). EndoC–bH1 cells and
the pancreatic islet sections were immunostained with guinea
pig anti-insulin, the novel mouse anti-ICA512 RESP18HD anti-
body, and the respective Alexa-conjugated secondary antibod-
ies, as described previously (20, 58). 49,6-Diamidino-2-phe-
nylindole dilactate was used for nuclei staining.
Aggregation reactions
Time course of ICA512 RESP18HD aggregation at 20 °C was
followed measuring scattered light as UV absorption at 400 nm.
The stock solution of ICA512 RESP18HD was prepared in 25
mM sodium acetate, pH 4.5. The reaction was started adding
ICA512 RESP18HD to a final concentration of 2 mM to 25 mM
HEPES adjusted to the indicated pH in the 4.5–7.4 range by
adding acetic acid or sodium hydroxide. To test the effect of
different metals and EDTA, these were added to the reaction
buffer, and the pH was readjusted to the desired value before
starting the measurements.
Coaggregation of ICA512 RESP18HD with insulin was
assayed by light scattering as indicated above. The reaction
was started adding insulin to ICA512 RESP18HD solutions,
resulting in 8 and 2 mM final concentration, respectively. Differ-
ent additives to the basic reaction were as described under
“Results.”
ThT fluorescence assay
To induce the formation of insulin amyloid cross-b-fibrils,
20 mM insulin in 100 mM HEPES, pH 6.8, was incubated for 1 h
at 60 °C with a stirring bar rotating at 150 rpm. At time 0 and at
the end of the incubation, samples were withdraw, diluted to 2
mM, and added to 2 mM ThT in the same buffer for immediate
fluorescence measurement. Excitation and emission wave-
length were 440 and 480 nm, respectively. ICA512 RESP18HD
and ICA512 RESP18HD–insulin aggregates formed by incuba-
tion at 20 °C were directly assayed for ThT fluorescence with-
out heating and stirring treatment.
Separation of aggregate proteins by centrifugation and
SDS-PAGE
The formation of higher-order protein aggregates was ana-
lyzed by centrifugation and SDS-PAGE. Typically, 10 mM
ICA512 RESP18HD with or without other proteins at a similar
concentration was incubated for 30 min in 100 ml of 100 mM
HEPES, pH 6.8. The samples were then spun for 5 min at 13,000
rpm in a microcentrifuge. The supernatant and pellet fractions
were TCA-precipitated, and pellets were dissolved in SDS-
PAGE sample buffer. Samples were heated for 5 min at 60 °C in
the presence of 100 mM DTT before loading into the SDS-poly-
acrylamide gel.
TEM
ICA512 RESP18HD aggregates, prepared as described above
after incubation alone or together with insulin, were pipetted
onto mesh grids equipped with a carbon film and incubated for
4 min. Afterward, excess fluid was removed, and the grids were
incubated with 1% uranyl formate solution for 30 s. After
removal of most of the staining solution, the grids were air-
dried. TEM images were acquired with a Tecnai 12 BioTwin
transmission electron microscope (FEI Co.) operated at 120 kV
equipped with a bottom-mount 2 3 2K F214 CCD camera
(TVIPS).
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